ATE449614T1 - Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika - Google Patents
Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutikaInfo
- Publication number
- ATE449614T1 ATE449614T1 AT04751990T AT04751990T ATE449614T1 AT E449614 T1 ATE449614 T1 AT E449614T1 AT 04751990 T AT04751990 T AT 04751990T AT 04751990 T AT04751990 T AT 04751990T AT E449614 T1 ATE449614 T1 AT E449614T1
- Authority
- AT
- Austria
- Prior art keywords
- radiopharmaceutics
- receptor antagonists
- vitronectin receptor
- targeting moiety
- receptor
- Prior art date
Links
- 102100022337 Integrin alpha-V Human genes 0.000 title 1
- 108010048673 Vitronectin Receptors Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 230000008685 targeting Effects 0.000 abstract 2
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003573 thiols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46972803P | 2003-05-12 | 2003-05-12 | |
| US84286204A | 2004-05-11 | 2004-05-11 | |
| PCT/US2004/014846 WO2004100996A1 (en) | 2003-05-12 | 2004-05-12 | Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449614T1 true ATE449614T1 (de) | 2009-12-15 |
Family
ID=33457156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04751990T ATE449614T1 (de) | 2003-05-12 | 2004-05-12 | Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060217292A1 (de) |
| EP (1) | EP1622647B1 (de) |
| JP (1) | JP2007505155A (de) |
| AT (1) | ATE449614T1 (de) |
| CA (1) | CA2525396A1 (de) |
| DE (1) | DE602004024299D1 (de) |
| MX (1) | MXPA05012109A (de) |
| WO (1) | WO2004100996A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2695384A1 (en) * | 2007-07-31 | 2009-02-05 | Burnham Institute For Medical Research | Bi-dentate compounds as kinase inhibitors |
| EP2559200A4 (de) | 2010-04-12 | 2015-04-22 | Qualcomm Inc | Erkennung von begrenzern von kommunikationen mit geringem overhead in einem netzwerk |
| JP2020523406A (ja) * | 2017-05-19 | 2020-08-06 | オクジェン アイエヌシー． | 眼科用組成物および使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9909420A (pt) * | 1998-03-31 | 2001-09-25 | Du Pont Pharm Co | Composto, kit, composição metalofarmacêutica de diagnóstico ou terapêutica, composição de agente de contraste de ultrassom, composição radiofarmacêutica terapêutica e composição radiofarmacêutica de diagnóstico |
| CN1356913A (zh) * | 1998-12-18 | 2002-07-03 | 杜邦药品公司 | 玻连蛋白受体拮抗剂药物 |
| EP1140203B1 (de) * | 1998-12-18 | 2007-05-23 | Bristol-Myers Squibb Pharma Company | Vitronektin rezeptor antagonist arzneimitteln oder diagnostika |
| EP1140864A2 (de) * | 1998-12-18 | 2001-10-10 | Du Pont Pharmaceuticals Company | Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend |
| CN1582166A (zh) * | 2000-06-21 | 2005-02-16 | 布里期托尔－迈尔斯斯奎布药品公司 | 在联合疗法中应用的玻璃粘连蛋白受体拮抗药物 |
| EP1311301A2 (de) * | 2000-07-06 | 2003-05-21 | Bristol-Myers Squibb Pharma Company | Stabile radiopharmazeutische formulierungen |
| JP2004537573A (ja) * | 2001-08-08 | 2004-12-16 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | 心臓灌流およびビトロネクチン受容体を標的とするイメージング剤の同時イメージング |
-
2004
- 2004-05-12 AT AT04751990T patent/ATE449614T1/de not_active IP Right Cessation
- 2004-05-12 CA CA002525396A patent/CA2525396A1/en not_active Abandoned
- 2004-05-12 US US10/555,804 patent/US20060217292A1/en not_active Abandoned
- 2004-05-12 MX MXPA05012109A patent/MXPA05012109A/es unknown
- 2004-05-12 JP JP2006532986A patent/JP2007505155A/ja active Pending
- 2004-05-12 EP EP04751990A patent/EP1622647B1/de not_active Expired - Lifetime
- 2004-05-12 DE DE602004024299T patent/DE602004024299D1/de not_active Expired - Fee Related
- 2004-05-12 WO PCT/US2004/014846 patent/WO2004100996A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05012109A (es) | 2006-02-08 |
| DE602004024299D1 (de) | 2010-01-07 |
| JP2007505155A (ja) | 2007-03-08 |
| WO2004100996A1 (en) | 2004-11-25 |
| EP1622647B1 (de) | 2009-11-25 |
| CA2525396A1 (en) | 2004-11-25 |
| US20060217292A1 (en) | 2006-09-28 |
| EP1622647A1 (de) | 2006-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
| DE122012000018I1 (de) | Benzimidazolderivate und ihre verwendung als antagonisten des a II rezeptors. | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| ATE413400T1 (de) | Cgrp-rezeptorantagonisten | |
| DE60228487D1 (de) | Ethylenediaminderivate und ihre verwendung als orexinrezeptorantagonisten | |
| DK1951660T3 (da) | Histamin-3-receptorantagonister | |
| ATE411323T1 (de) | Cgrp-rezeptorantagonisten | |
| DE602004027998D1 (de) | Kondensierte n-heterozyclische verbindung und ihre verwendung als crf-rezeptor antagonist | |
| ATE484505T1 (de) | 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten | |
| ATE286897T1 (de) | Morpholinderivate als antagonisten an orexinrezeptoren | |
| ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
| ATE414074T1 (de) | 2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl- piperidine als cgrp-antagonisten | |
| DE602007008434D1 (de) | Rezeptoren | |
| ATE500250T1 (de) | Azetidinverbindungen als orexin-rezeptor- antagonisten | |
| EA200701121A1 (ru) | Потенциаторы рецепторов глутамата | |
| ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
| DE60320529D1 (de) | Chinolinderivate als npy antagonisten | |
| ATE421511T1 (de) | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors | |
| DE60331751D1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
| MX2009005363A (es) | Pirimidinas y su uso como antagonistas del receptor cxcr2. | |
| ATE429428T1 (de) | Indanderivate als antagonisten des mch-rezeptors | |
| DE602005027230D1 (de) | Cgrp-rezeptorantagonisten | |
| ATE507880T1 (de) | Cgrp-rezeptorantagonisten | |
| DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
| DE60238709D1 (de) | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |